Literature DB >> 10940359

Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys.

M C Ko1, K J Willmont, A Burritt, V J Hruby, J H Woods.   

Abstract

Although dynorphin A-(1-17) has been characterized in vitro as a high efficacy kappa-opioid receptor agonist, functional studies of dynorphin A-(1-17) following central or systemic administration indicate the involvement of both opioid and non-opioid components. The aim of this study was to investigate whether local administration of dynorphin-related analogs can attenuate capsaicin (8-methyl-N-vanillyl-6-nonenamide)-induced nociception and what type of opioid receptor mediates the local action of dynorphin A-(1-17) in monkeys. Capsaicin (100 microg) was used to evoke a nociceptive response, thermal allodynia, which was manifested as a reduced tail-withdrawal latency in normally innocuous 46 degrees C warm water. Co-administration of dynorphin A-(1-17) (0.3-10 microg) with capsaicin in the tail dose-dependently inhibited thermal allodynia; however, both non-opioid fragments dynorphin A-(2-17) (10-300 microg) and dynorphin A-(2-13) (10-300 microg) were ineffective. Local antiallodynia of dynorphin A-(1-17) was antagonized by a small dose (100 microg) of an opioid receptor antagonist, quadazocine, applied s.c. in the tail. Pretreatment with a selective kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), s.c. 320 microg in the tail also reversed local antiallodynia of dynorphin A-(1-17). Both locally effective doses of antagonists, when applied s.c. in the back, did not antagonize local dynorphin A-(1-17), indicating that peripheral kappa-opioid receptors selectively mediated the local action of dynorphin A-(1-17) in the tail. In addition, a much larger dose of dynorphin A-(1-17) (1000 microg), when administered s. c. in the back or i.m. in the thigh, did not cause sedative or diuretic effects. These results suggest that in vivo opioid actions of dynorphin-related peptides can be differentiated locally in this procedure. They also indicate that local application of peptidic ligands may be a useful medication for localized pain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940359      PMCID: PMC2850053          DOI: 10.1016/s0014-2999(00)00503-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  40 in total

1.  A model of transient hyperalgesia in the behaving monkey induced by topical application of capsaicin.

Authors:  R C Kupers; C C Chen; M C Bushnell
Journal:  Pain       Date:  1997-08       Impact factor: 6.961

2.  In vitro biotransformation of dynorphin A (1-17) is similar in human and rhesus monkey blood as studied by matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  J Yu; E R Butelman; J H Woods; B T Chait; M J Kreek
Journal:  J Pharmacol Exp Ther       Date:  1996-11       Impact factor: 4.030

3.  The capsaicin receptor: a heat-activated ion channel in the pain pathway.

Authors:  M J Caterina; M A Schumacher; M Tominaga; T A Rosen; J D Levine; D Julius
Journal:  Nature       Date:  1997-10-23       Impact factor: 49.962

4.  kappa-Opioid receptor binding populations in rhesus monkey brain: relationship to an assay of thermal antinociception.

Authors:  E R Butelman; M C Ko; K Sobczyk-Kojiro; H I Mosberg; B Van Bemmel; G Zernig; J H Woods
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

5.  Peripheral and spinal actions of opioids in the blockade of the autonomic response evoked by compression of the inflamed knee joint.

Authors:  H Nagasaka; H Awad; T L Yaksh
Journal:  Anesthesiology       Date:  1996-10       Impact factor: 7.892

6.  Antinociceptive effects of dynorphin peptides in a model of inflammatory pain.

Authors:  A Beyer; M Schäfer; C Stein
Journal:  Pain       Date:  1997-04       Impact factor: 6.961

7.  Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor.

Authors:  V K Shukla; J A Prasad; S Lemaire
Journal:  J Pharmacol Exp Ther       Date:  1997-11       Impact factor: 4.030

8.  Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone.

Authors:  T W Vanderah; T Laughlin; J M Lashbrook; M L Nichols; G L Wilcox; M H Ossipov; T P Malan; F Porreca
Journal:  Pain       Date:  1996-12       Impact factor: 6.961

9.  Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.

Authors:  J Zhu; L Y Luo; J G Li; C Chen; L Y Liu-Chen
Journal:  J Pharmacol Exp Ther       Date:  1997-08       Impact factor: 4.030

10.  Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family.

Authors:  S Zhang; Y Tong; M Tian; R N Dehaven; L Cortesburgos; E Mansson; F Simonin; B Kieffer; L Yu
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

View more
  4 in total

1.  Orphanin FQ inhibits capsaicin-induced thermal nociception in monkeys by activation of peripheral ORL1 receptors.

Authors:  M C H Ko; N N Naughton; J R Traynor; M S Song; J H Woods; K C Rice; A T McKnight
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Pleiotropic Effects of Kappa Opioid Receptor-Related Ligands in Non-human Primates.

Authors:  Mei-Chuan Ko; Stephen M Husbands
Journal:  Handb Exp Pharmacol       Date:  2020-12-04

3.  Aqueous humor dynamics in monkeys in response to the kappa opioid agonist bremazocine.

Authors:  Carol A Rasmussen; B'Ann True Gabelt; Paul L Kaufman
Journal:  Trans Am Ophthalmol Soc       Date:  2007

Review 4.  Translational value of non-human primates in opioid research.

Authors:  Huiping Ding; Mei-Chuan Ko
Journal:  Exp Neurol       Date:  2021-01-14       Impact factor: 5.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.